Leukemia and lymphoma incidence in rodents exposed to low-frequency magnetic fields

Radiation Research

Volumn 153, Issue 5 II SUPPL., 2000, Pages 627-636

  Boorman, Gary A ^a   Rafferty, Charles N ^b   Ward, Jerrold M ^c   Sills, Robert C ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b ELECTRIC POWER RESEARCH INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOASSAY; CANCER INCIDENCE; DATA ANALYSIS; DISEASE ASSOCIATION; FREQUENCY ANALYSIS; LEUKEMIA; LYMPHOMA; MAGNETIC FIELD; MOUSE; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; TRANSGENE; TUMOR GROWTH;

EID: 0034059423     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2000)153[0627:laliir]2.0.co;2     Document Type: Article

References (69)

1. Assessment of Health Effects from Exposure to Power-Line Frequency Electric and Magnetic Fields, p. 508. Working Group Report, National Institute of Environmental Health Sciences of the National Institutes of Health, 1998.
2. L. M. Green, A. B. Miller, P. J. Villeneuve, D. A. Agnew, M. L. Greenberg, J. Li and K. B. Donnelly, A case-control study of childhood leukemia in southern Ontario, Canada, and exposure to magnetic fields in residences. Int. J. Cancer 82, 161-170 (1999).
3. J. Michaelis, J. Schuz, R. Meinert, M. Menger, J. P. Grigat, P. Kaatsch, U. Kaletsch, A. Miesner, A. Stamm and H. Karner, Childhood leukemia and electromagnetic fields: Results of a population-based case-control study in Germany. Cancer Causes Control 8, 167-174 (1997).
4. T. Sorahan, L. Hamilton, K. Gardiner, J. T. Hodgson and J. M. Harrington, Maternal occupational exposure to electromagnetic fields before, during, and after pregnancy in relation to risks of childhood cancers: Findings from the Oxford survey of childhood cancers, 1953-1981 deaths. Am. J. Ind. Med. 35, 348-357 (1999).
5. L. I. Kheifets, A. A. Afifi, P. A. Buffler, Z. W. Zhang and C. C. Matkin, Occupational electric and magnetic field exposure and leukemia. A metaanalysis. J. Occup. Environ. Med. 39, 1074-1091 (1997).
6. L. I. Kheifets, S. J. London and J. M. Peters, Leukemia risk and occupational electric field exposure in Los Angeles County, California. Am. J. Epidemiol. 146, 87-90 (1997).
7. M. L. McBride, R. P. Gallagher, G. Theriault, B. G. Armstrong, S. Tamaro, J. J. Spinelli, J. E. Deadman, S. Fincham, D. Robson and W. Choi, Power-frequency electric and magnetic fields and risk of childhood leukemia in Canada. Am. J. Epidemiol. 149, 831-842 (1999).
8. M. S. Linet, E. E. Hatch, R. A. Kleinerman, L. L. Robison, W. T. Kaune, D. R. Friedman, R. K. Severson, C. M. Haines, C. T. Hartsock and R. E. Tarone, Residential exposure to magnetic fields and acute lymphoblastic leukemia in children. N. Engl. J. Med. 337, 1-7 (1997).
9. J. E. Moulder, Power-frequency fields and cancer. Crit. Rev. Biomed. Eng. 26, 1-116 (1998).
10. NIEHS Report on health effects from exposure to power-line frequency electric and magnetic fields. In Prepared in Response to the 1992 Energy Policy Act (PL 102-486, Section 2118), p. 67. U.S. Printing Office, Research Triangle Park, NC, 1999.
11. J. Wilbourn, L. Haroun, E. Heseltine, J. Kaldor, C. Partensky and H. Vainio, Response of experimental animals to human carcinogens: An analysis based upon the IARC monographs programme. Carcinogenesis 7, 1853-1856 (1986).
12. R. A. E. Thomson, S. M. Michaelson and Q. A. Nguyen, Influence of 60-hertz magnetic fields on leukemia. Bioelectromagnetics 9, 149-158 (1988).
13. W. Z. Fam and E. L. Mikhail, Lymphoma induced in mice chronically exposed to very strong low-frequency electromagnetic field. Cancer Lett. 105, 257-269 (1996).
14. Y. H. Shen, B. J. Shao, H. Chiang, Y. D. Fu and M. Yu, The effects of 50 Hz magnetic field exposure on dimethylbenz(a)anthracene induced thymic lymphoma/leukemia in mice. Bioelectromagnetics 18, 360-364 (1997).
15. A. W. Harris, A. Basten, V. Gebski, D. Noonan, J. Finnie, M. L. Bath, M. J. Bangay and M. H. Repacholi, A test of lymphoma induction by long-term exposure of Eμ-Pim1transgenic mice to 50 Hz magnetic fields. Radiat Res. 149, 300-310 (1998).
16. G. A. Boorman, D. L. McCormick, J. C. Findlay, J. R. Hailey, J. R. Gauger, T. R. Johnson, R. M. Kovatch, R. C. Sills and J. K. Haseman, Chronic toxicity/oncogenicity of 60 Hz (power frequency) magnetic fields in F344/N rats. Toxicol. Pathol. 27, 267-278 (1999).
17. 1 mice. Toxicol. Pathol. 27, 279-285 (1999).
18. R. Mandeville, E. Franco, S. Sidrac-Ghali, L. Paris-Nadon, N. Rocheleau, G. Mercier, M. Desy and L. Gaboury, Evaluation of the potential carcinogenicity of 60 Hz linear sinusoidal continuous-wave magnetic fields in Fischer F344 rats. FASEB J. 11, 1127-1136 (1997).
19. Toxicology and carcinogenesis studies of 60-Hz magnetic fields administered by whole body exposure to F344/N rats and B6C3F1 mice (whole body exposure studies). NTP TR 488, NIH Publication No. 99-3978, Research Triangle Park, NC, 1999.
20. M. Yasui, T. Kikuchi, M. Ogawa, Y. Otaka, M. Tsuchitani and H. Iwata, Carcinogenicity test of 50 Hz sinusoidal magnetic fields in rats. Bioelectromagnetics 18, 531-540 (1997).
21. D. L. McCormick, B. M. Ryan, J. C. Findlay, J. R. Gauger, T. R. Johnson, R. L. Morrissey and G. A. Boorman, Magnetic field exposure and risk of lymphoma in PIM transgenic and TSG-p53 (p53 knockout) mice. Carcinogenesis 19, 1649-1653 (1998).
22. L. B. Sasser, J. E. Morris, D. L. Miller, C. N. Rafferty, K. L. Ebi and L. E. Anderson, Exposure to 60 Hz magnetic fields does not alter clinical progression of LGL leukemia in Fischer rats. Carcinogenesis 17, 2681-2687 (1996).
23. J. E. Morris, L. B. Sasser, D. L. Miller, G. E. Dagle, C. N. Rafferty, K. L. Ebi and L. E. Anderson, Clinical progression of transplanted large granular lymphocytic leukemia in Fischer 344 rats exposed to 60 Hz magnetic fields. Bioelectromagnetics 20, 48-56 (1999).
24. L. E. Anderson, L. B. Sasser, J. E. Morris and D. L. Miller, Large Granular Lymphocytic (LGL) Leukemia in Rats Exposed to 60 Hz Magnetic Fields: Results of the Second Study Using Continuous and Intermittent Fields. TR 109469, Electric Power Research Institute, Palo Alto, CA, 1997.
25. J. T. Babbitt, A. I. Kharazi, J. M. G. Taylor, C. N. Rafferty, R. Kovatch, C. B. Bonds, S. G. Mirell, E. Frumkin, E Dietrich, D. Zhuang and T. J. M. Hahn, Leukemia/Lymphoma in Mice Exposed to 60-Hz Magnetic Fields: Results of the Chronic Exposure Study, 2nd ed. TR 110338-R1, Electric Power Research Institute, Palo Alto, CA, 1999.
26. J. Aster and V. Kumar. White cells, lymph nodes, spleen and thymus. In Robbins Pathologic Basis of Disease, 6th ed. (R. S. Cotran, V. Kumar and T. Collins, Eds.), pp. 644-687. W. B. Saunders, Philadelphia, 1999.
27. L. L. Robison and J. A. Ross, Epidemiology of leukaemias and lymphomas in childhood. In Baillière's Clinical Paediatrics, International Practice and Research, Vol. 3, No. 4 (J. M. Chessells and I. M. Hahn, Eds.), pp. 639-657. Baillière Tindall, London, 1995.
28. A. Biondi and G. Masera, Molecular pathogenesis of childhood acute lymphoblastic leukemia. Haematologica 83, 651-659 (1998).
29. J. E. Rubnitz, J. R. Downing and W. M. Crist, Pathobiology and clinical significance of molecular genetic findings in childhood tumors. Adv. Pediatr. 45, 315-336 (1998).
30. N. A. Heerema, Cytogenetics of leukemia. Cancer Invest. 16, 127-134 (1998).
31. M. F. Greaves, Aetiology of acute leukaemia. Lancet 349, 344-349 (1997).
32. J. D. Siebert, D. A. Mulvaney, K. L. Potter, P. A. Fishkin and F. J. Geoffroy, Relative frequencies and sites of presentation of lymphoid neoplasms in a community hospital according to the revised European-American classification. Am. J. Clin. Pathol. 111, 379-386 (1999).
33. - large granular lymphocyte leukemia. Blood 92, 4771-4777 (1998).
34. R. R. Severson and J. A. Ross, The causes of acute leukemia. Curr. Opin. Oncol. 11, 20-24 (1999).
35. D. P. Sandler and J. A. Ross, Epidemiology of acute leukemia in children and adults. Semin. Oncol. 24, 3-16 (1997).
36. V. G. Vogel and R. E. Fisher, Epidemiology and etiology of leukemia. Curr. Opin. Oncol. 5, 26-34 (1993).
37. M. Feychting and A. Ahlbom, Childhood leukemia and residential exposure to weak extremely low frequency magnetic fields. Environ. Health Perspect. 103, 59-62 (1995).
38. T. Lehtinen and M. Lehtinen, Common and emerging infectious causes of hematological malignancies in the young. APMIS 106, 585-597 (1998).
39. J. Wilbourn, L. Haroun, H. Vainio and R. Montesano, Identification of chemicals carcinogenic to man. Toxicol. Pathol. 12, 397-399 (1984).
40. N. Wertheimer and E. Leeper, Electrical wiring configurations and childhood cancer. Am. J. Epidemiol. 109, 273-284 (1979).
41. D. A. Savitz, H. Wachtel, F. A. Barnes, E. M. John and J. G. Tvrdik, Case-control study of childhood cancer and exposure to 60-Hz magnetic fields. Am. J. Epidemiol. 128, 21-38 (1988).
42. D. A. Savitz, Overview of epidemiologic research on electric and magnetic fields and cancer. Am. Ind. Hyg. Assoc. J. 54, 197-204 (1993).
43. B. Floderus, T. Persson, C. Stenlund, A. Wennberg, A. Ost and B. Knave, Occupational exposure to electromagnetic fields in relation to leukemia and brain tumors. Cancer Causes Control 4, 465-476 (1993).
44. M. Feychting, Occupational exposure to electromagnetic fields and adult leukemia: A review of the epidemiological evidence. Radiat. Environ. Biophys. 35, 237-242 (1996).
45. D. A. Savitz and D. P. Loomis, Magnetic field exposure in relation to leukemia and brain cancer mortality among electric utility workers. Am. J. Epidemiol. 141, 123-134 (1995).
46. L. Tomatis, A. Aitio, J. Wilbourn and L. Shuker, Human carcinogens so far identified. Jpn. J. Cancer Res. 80, 795-807 (1989).
47. J. M. Ward, P. C. Mann, H. Morishima and C. H. Frith, Thymus, spleen and lymph nodes. In Pathology of the Mouse (R. R. Maronpot, G. A. Boorman and B. W. Gaul, Eds.), pp. 333-360. Cache River Press, Vienna, IL, 1999.
48. M. G. Narducci, L. Virgilio, J. B. Engiles, A. M. Buchberg, L. Billips, A. Facchiano, C. M. Croce, G. Russo and J. L. Rothstein, The murine Tell oncogene: embryonic and lymphoid expression. Oncogene 15, 919-926 (1997).
49. M. Plumb, H. Cleary and E. Wright, Genetic instability in radiation-induced leukaemias: Mouse models. Int. J. Radiat. Biol. 74, 711-720 (1998).
50. G. H. Reaman, Drug development and chemotherapy in acute lymphoblastic leukemia: of mice to men. Cancer 83, 1885-1888 (1998).
51. J. M. Ward and C. W. Reynolds, Large granular lymphocyte leukemia; A heterogeneous lymphocytic leukemia in F344 rats. Am. J. Pathol. 111, 1-10 (1983).
52. P. C. Stromberg, J. L. Rojko, L. M. Vogtsberger, C. Cheney and R. Berman, Immunologic, biochemical, and ultrastructural characterization of the leukemia cell in F344 rats. J. Natl. Cancer Inst. 71, 173-181 (1983).
53. A. Lacy-Hulbert, J. C. Metcalfe and R. Hesketh, Biological responses to electromagnetic fields. FASEB J. 12, 395-420 (1998).
54. J. McCann, F. Dietrich and C. N. Rafferty, The genotoxic potential of electric and magnetic fields - An update. Mutat. Res. 411, 45-86 (1998).
55. J. McCann, F. Dietrich, C. Rafferty and A. O. Martin, A critical review of the genotoxic potential of electric and magnetic fields. Mutat. Res. 297, 61-95 (1993).
56. P. K. Pattengale, Animal model of lymphoid cell neoplasia. In Lymphoproliferative Disease: Pathogenesis, Diagnosis, and Therapy (P. K. Pattengale, R. J. Lukes and C. R. Taylor, Eds.), pp. 36-44. Martinus Nijhoff, The Hague, 1985.
57. P. K. Pattengale, Tumours of the lymphohaematopoietic system. In Pathology of Tumours in Laboratory Animals; Tumours of the Mouse, 2nd ed. (V. S. Turusov and U. Mohr, Eds.), pp. 651-670. International Agency for Research on Cancer, Lyon, 1994.
58. J. R. Maisin, A. Wambersie, G. B. Gerber, G. Mattelin, M. Lambiet-Collier, B. De Coster and J. Gueulette, Life-shortening and disease incidence in C57B1 mice after a single and fractionated gamma and high-energy neutron exposure. Radiat. Res. 113, 300-317 (1988).
59. H. Hiai, Genetic predisposition to lymphomas in mice. Pathol. Int. 46, 707-718 (1996).
60. J. Boniver, C. Humblet, A. M. Rongy, C. Delvenne, P Delvenne, R. Greimers, A. Thiry, R. Courtoy and M. P. Defresne, Cellular aspects of the pathogenesis of radiation-induced thymic lymphomas in C57 B1 mice. In Vivo 4, 41-43 (1990).
61. C. F. van Kreijl, C. W. van der Houven van Oordt, E. D. Kroese, I. K. Sorensen, M. L. Breuer and R. D. Storer, Evaluation of the Eμ-Pim-1 transgenic mouse model for short-term carcinogenicity testing. Toxicol. Pathol. 26, 750-756 (1998).
62. C. S. Trempus, J. F. Mahler, H. N. Ananthaswamy, S. M. Loughlin, J. E. French and R. W. Tennant, Photocarcinogenesis and susceptibility to UV radiation in the v-Ha-ras transgenic Tg.AC mouse. J. Invest. Dermatol. 111, 445-451 (1998).
63. C. W. van der Houven van Oordt, T. G. Schouten, J. H. van Krieken, J. H. van Dierendonck, A. J. van der Eb and M. L. Breuer, X-ray-induced lymphomagenesis in Eμ-Pim-1 transgenic mice: An investigation of cooperating molecular events. Carcinogenesis 19, 847-853 (1998).
64. G. Li, V. Tron and V. Ho, Induction of squamous cell carcinoma in p53-deficient mice after ultraviolet irradiation. J. Invest. Dermatol 110, 72-75 (1998).
65. D. Wingett, A. Long, D. Kellcher and N. S. Magnuson, Pim-1 protooncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1. J. Immunol. 156, 549-557 (1996).
66. B. M. Svedenstal and B. Holmberg, Lymphoma development among mice exposed to X-rays and pulsed magnetic fields. Int. J. Radiat. Biol. 64, 119-125 (1993).
67. 125I incorporation in vivo after exposure to a 50 Hz magnetic field. In Vivo 12, 531-534 (1998).
68. M. H. Repacholi, A. Basten, V. Gebski, D. Noonan, J. Finnie and A. W. Harris, Lymphomas in Eμ-Pim-1transgenic mice exposed to pulsed MHz electromagnetic fields. Radiat. Res. 147, 631-640 (1997).
69. A. Bellossi, Effect of pulsed magnetic fields on leukemia-prone AKR mice. No effect on mortality through five generations. Leuk. Res. 15, 899-902 (1991).